Study of INV-202 in Patients With Obesity and Metabolic Syndrome
Clinical trial NCT05891834 · COMPLETED
Trial details
- NCT number
- NCT05891834
- Sponsor
- Inversago Pharma Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-08
- Primary completion
- 2024-06-13
- Enrollment
- 243
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.